Effects of a single intratympanic gentamicin injection on Meniere's disease

Acta Oto-Laryngologica

Volumn 127, Issue SUPPL. 558, 2007, Pages 61-66

  Chung, Won Ho ^a,b   Chung, Kyu Whan ^a   Kim, Joon Ho ^a   Cho, Yang Sun ^a   Hong, Sung Hwa ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Gentamicin; Hearing loss; Intratympanic injection; Meniere's disease; Vertigo

Indexed keywords

GENTAMICIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FUNCTIONAL STATUS; HUMAN; INJECTION; MALE; MENIERE DISEASE; PERCEPTION DEAFNESS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; VERTIGO;

EID: 34648818171     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/03655230701624889     Document Type: Article

References (20)

1. Lange G. [The intratympanic treatment of Meniere's disease with ototoxic antibiotics. A follow-up study of 55 cases (author's transl)]. Laryngol Rhinol Otol (Stuttg) 1977;56:409-14.
2. Rauch SD, Oas JG. Intratympanic gentamicin for treatment of intractable Meniere's disease: a preliminary report. Laryngoscope 1997;107:49-55.
3. Toth AA, Parnes LS. Intratympanic gentamicin therapy for Meniere's disease: preliminary comparison of two regimens. J Otolaryngol 1995;24:340-4.
4. Minor LB. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy. Am J Otol 1999;20:209-19.
5. Longridge NS, Mallinson AI. Low-dose intratympanic gentamicin treatment for dizziness in Meniere's disease. J Otolaryngol 2000;29:35-9.
6. Lange G, Maurer J, Mann W. Long-term results after interval therapy with intratympanic gentamicin for Meniere's disease. Laryngoscope 2004;114:102-5.
7. Chia SH, Gamst AC, Anderson JP, Harris JP. Intratympanic gentamicin therapy for Meniere's disease: a meta-analysis. Otol Neurotol 2004;25:544-52.
8. Blakley BW. Update on intratympanic gentamicin for Meniere's disease. Laryngoscope 2000;110:236-40.
9. Monsell E, cass S, Rybak L. Therapeutic use of aminoglycosides in Meniere's disease. Otolaryngol Clin North Am 1993;26:737-46.
10. Hayashida T, Hiel H, Dulon D. Dynamic changes following combined treatment with gentamicin and ethacrynic acid with and without acoustic stimulation. Cellular uptake and functional correlates. Acta Otolaryngol 1989;108:404-13.
11. Kaplan DM, Nedzelski JM, Chen JM, Shipp DB. Intratympanic gentamicin for the treatment of unilateral Meniere's disease. Laryngoscope 2000;110:1298-305.
12. Martin E, Perez N. Hearing loss after intratympanic gentamicin therapy for unilateral Meniere's Disease. Otol Neurotol 2003;24:800-6.
13. Quaranta A, Scaringi A, Aloidi A, Quaranta N, Salonna I. Intratympanic therapy for Meniere's disease: effect of administration of low concentration of gentamicin. Acta Otolaryngol 2001;121:387-92.
14. Tange R, Conijn E. Pattern of gentamicin-induced cochlear degeneration in the guinea pig. A morphological and electrophysiological study. Arch Otorhinolaryngol 1982;236:173-84.
15. Chung W, Lee W, Moon S. Streptomicin perfusion through the round window in Meniere's disease. Korean J Otolaryngol 1998;41:725-9.
16. Harner S, Driscoll C. Longterm follow up of transtympanic gentamicin for Meniere's syndrome. Otol Neurotol 2001;22:210-4.
17. Bagger-Sjoback D, Bergenius J. Longterm follow-up of transtympanic gentamicin for Meniere's disease. Am J Otol 1990;11:406-10.
18. Hiel H, Bennani H, Erre J. Kinetics of gentamicin in cochlear hair cells after chronic treatment. Acta Otolaryngol 1992;112:272-7.
19. Takumida M, Wersall J. Initial changes in the sensory hair cell membrane following aminoglycoside administration in a guinea pig model. Arch Otorhinolaryngol 1989;246:26-31.
20. Walsted A. Unpredictable hearing loss after intratympanic gentamicin treatment for vertigo. A new theory. Acta Otolaryngol 2001;121:42-4.